Instanz: TeilenTeilen:Study Examines the Consequences of Discontinuing GLP-1 Medications on Addiction-Related HospitalizationsTorsten Lauer Referat Kommunikation und MedienZentralinstitut für Seelische Gesundheit21.07.2026 13:55People with type 2 diabetes were hospitalized less frequently for alcohol or substance use disorders while undergoing treatment with GLP-1 receptor agonists. This is shown by a large Swedish registry study involving the Central Institute of Mental Health (CIMH). GLP-1 receptor agonists are among the active ingredients in so-called weight-loss injections. Effects Not Statistically Significant After Treatment EndsDuring treatment with GLP-1 receptor agonists, alcohol- and substance-related hospitalizations were less frequent than during treatment-free periods. “The data underscore the importance of careful monitoring and follow-up of patients after the end of treatment with GLP-1 receptor agonists,” Bach emphasizes.